3rd Quarter - Report

DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE

Firm
Client
Income
—
Expenses
$50,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 2855, Drug Overdose Reduction Act, issues relating to reducing drug overdoses H.R. 5678, Universal Access to Methamphetamine Treatment Act of 2010, issues relating to treatment for methamphetamine misuse. Issues relating to Appropriations for the National Youth Anti-Drug Media Campaign

LobbyistCovered position, as disclosed
BILL J PIPER —
GRANT SMITH —
JASMINE TYLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2855 (111th), H.R. 5678 (111th)

Law Enforcement/Crime/Criminal Justice LAW

H.R. 3245, Fairness in Cocaine Sentencing Act of 2009, issues relating to the crack/powder sentencing disparity S. 714, National Criminal Justice Commission Act of 2009, issues relating to over-incarceration S. 258, Saving Kids from Dangerous Drugs Act of 2010, issues relating to federal sentencing Issues relating to the reauthorization of the Office of National Drug Control Policy

LobbyistCovered position, as disclosed
EMILY BROOKS —
BILL J PIPER —
GRANT SMITH —
JASMINE TYLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 714 (111th), H.R. 3245 (111th), S. 258 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.